Publication

HCV elimination: time is ticking

Without treatment for their hepatitis C, the health of patients can deteriorate…

Learn more
Click here
Publication

Reaching out in the darkness

When it comes to marginalised patients with hepatitis C, every street corner…

Learn more
Click here
Publication

NASH and diabetes: the importance of collaboration between liver and diabetes specialists

Dr Kenneth Cusi, Chief of the Division of Endocrinology and Diabetes at…

Learn more
Click here
Publiacations & Events
Publication

Expert insights from the EASL NAFLD Summit 2019

Dr Javier Ampuero (University of Seville, Spain) attended key sessions during the…

Learn more
Click here
Publication

Testing and treating HCV in marginalised populations

Of the estimated 3.2 million people with chronic HCV in the European…

Learn more
Click here
Publication

GILEAD AWARDS 19 GRANTS SUPPORTING THE ELIMINATION OF HEPATITIS C IN 12 COUNTRIES ACROSS EUROPE, MIDDLE EAST AND AUSTRALIA

On Tuesday 15th October 2019, Gilead Sciences announced the recipients of its…

Learn more
Click here

Categories

Popular Posts

Project support

GILEAD AWARDS 19 GRANTS SUPPORTING THE ELIMINATION OF HEPATITIS C IN 12 COUNTRIES ACROSS EUROPE, MIDDLE EAST AND AUSTRALIA

Read more
Project support

The Trap Hep C programme in Iceland

Read more
Project support

Gilead’s investigator-sponsored research program: STAT

Read more
Header Image

Find comprehensive resources in our HCV, HBV and NAFLD and NASH toolkits

LID/IHQ/18-12//1048(3) Date of preparation: September 2019